|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 160-166. Prepublished online as a Blood First Edition Paper on March 14, 2006; DOI 10.1182/blood-2005-09-3706.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Zebrafish G protein
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and methodsResultsDiscussionReferences |
|---|
2) blocks the normal angiogenic process in developing zebrafish embryos. Moreover, loss of gng2 function inhibits the ability of VEGF to promote the angiogenic sprouting of blood vessels by attenuating VEGF induced phosphorylation of phospholipase C-gamma1 (PLC1) and serine/threonine kinase (AKT). Collectively, these results demonstrate a novel interaction between G2- and VEGF-dependent pathways to regulate the angiogenic process in a whole-animal model. Blocking VEGF function using a humanized anti-VEGF antibody has emerged as a promising treatment for colorectal, non-small lung cell, and breast cancers. However, this treatment may cause considerable side effects. Our findings provide a new opportunity for cotargeting G protein- and VEGF-dependent pathways to synergistically block pathologic angiogenesis, which may lead to a safer and more efficacious therapeutic regimen to fight cancer. (Blood. 2006;108:160-166) |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionReferences |
|---|
|
Materials and methods |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionReferences |
|---|
Danio rerio Florida wild-type (WT) strain (That Fish Place, Lancaster, PA) and longfin strain (Scientific Hatcheries, Huntington Beach, CA) were used.
mRNA overexpression
vegf121 overexpression construct in pCS2+ vector was kindly provided by Dr Brant Weinstein.5 Zebrafish gng2 overexpression construct was generated by subcloning the gng2 open reading frame (without any intron sequences) into ClaI/XhoI sites of pCS2+ vector. Since the gng2 RNA does not contain the intron sequences targeted by the splicing morpholino, this gng2 RNA can be used, in combination with the splicing morpholino, for the RNA rescue experiment. Capped sense RNA was synthesized using SP6 RNA polymerase and the mMESSAGE mMACHINE system (Ambion, Austin, TX). For microinjection of vegf121 mRNA, zebrafish gng2 mRNA, or morpholino antisense oligos, zebrafish embryos were injected at the 1-cell stage, followed by incubation in 0.3 x Danieau medium at 28.5°C. Embryos were maintained in this condition until they had reached tailbud stage for total RNA preparation, or 1 day after fertilization (dpf) to 4 dpf for whole-mount in situ hybridization.6 The Genbank accession number for zebrafish gng2 is DQ109815 [GenBank] ; the Genbank accession number for zebrafish vegf121 is AF059661 [GenBank] (http://www.ncbi.nlm.nih.gov).
Antisense morpholino oligos
Morpholinos were synthesized by GeneTools LLC (Philomath, OR). Following are the sequences for various morpholinos: gng2-MO (Splicing antisense), 5'_TATGCTCTTTCTGACCTTTATTCTG; gng2-ATG-MO (translational blocking antisense), 5'_GCCATGAGGCTGGCGGTTCAGGC; 5-mismatch-MO, 5'_GCAATCAGGCTAGCGGTTAAGCC; and vegf-MO (translational blocking), 5'_GTATCAAATAAACAACCAAGTTCAT.
In situ hybridization
The flk1 in situ construct was kindly provided by Dr Brant Weinstein5 (National Institutes of Health, Bethesda, MD; gng2 accession no. DQ109815 [GenBank] ). In situ hybridization was modified from Leung et al.6 In brief, embryos were hybridized at 68°C overnight with antisense probe in hybridization buffer (Hyb), then washed at 68°C by 66% Hyb/33% 2 x sodium citrate buffer, pH 7.0 (SSC) for 30 minutes, 33% Hyb/66% 2 x SSC for 30 minutes, 2 x SSC for 15 minutes, and 0.2 x SSC for 1 hour. After color staining with NBT/BCIP (Roche, Indianapolis, IN), the embryos were washed in 100% ethanol for 1 hour. Zebrafish embryos were documented using an MZFL3 stereomicroscope (Leica Microsystems, Wetzlar, Germany) equipped with a Plan-Apo 10 x/0.125 NA objective lens, a DEI-750D CE digital video camera (Optronics, Goleta, CA), and ImagePro+ version 4.1 software (Media Cybernetics, Silver Spring, MD).
RT-PCR
Trizol (Invitrogen, Carlsbad, CA) was used to isolate total RNA from 10 uninjected (WT) embryos and 10 embryos injected with 1 nL of 100 µM morpholino antisense oligo. After treatment with RQ1 DNase, 1 µg RNA was reverse-transcribed using Moloney murine leukemia virus (MMLV) Reverse Transcriptase (RT; Promega, Madison, WI). Polymerase chain reaction (PCR) of the cDNA using Titanium Taq (BD Biosciences, San Jose, CA) for 30 and 26 cycles with gng2 primers and 28S ribosomal subunit primers, respectively: gng2 primers (forward: 5'_atcgatatggccaccaacaacacagcta and reverse: 5'_ttacaggatggcacagaagaac); and 28S subunit primers (forward: 5'_cctcacgatccttctggctt and reverse: 5'_attctgcttcacaatgata). Plasmids containing gng2 genomic sequence or cDNA sequence were amplified as positive controls.
Detection of MO translation inhibition by in vitro system
The efficacy of the MO was assessed in an in vitro transcription and translation-coupled system (TNT Coupled Reticulocyte Lysate Systems; Promega). The BamHI/XhoI gng2 PCR fragment was cloned into pcDNA3.1/V5-His-TOPO (Invitrogen). gng2 cDNA (0.5 µg) was used as template and different MO oligos were added. Western blotting was performed using anti-V5 antibody (Invitrogen). The immunoreactive proteins were detected by enhanced chemiluminescence (Amersham Pharmacia, Piscataway, NJ).
Whole-mount immunostaining
Embryos were fixed in 4% paraformaldehyde overnight, washed in phosphate-buffered saline with Tween 2 (PBST) and blocked in PBST containing 2% goat serum and 2% bovine serum albumin (BSA) for 2 hours at 4°C. Primary antibodies against phospho-serine/threonine kinase (AKT) and phospho-phospholipase C-gamma1 (PLC1) (Cell Signaling Technology, Danvers, MA) were used in 1:100 dilution in blocking buffer at 4°C overnight. After washing in PBST, secondary antibody was used in 1:300 dilution at 4°C overnight. All these solutions contain 20 mM sodium fluoride and 2 mM sodium orthovanadate (Sigma, St Louis, MO). Color detection was done by DAB staining (Sigma).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionReferences |
|---|
In addition to the prominent roles played by receptor tyrosine kinases, G protein-coupled receptors (GPCRs)7-11 and their associated G proteins12,13 are emerging as important regulators of blood-vessel development. Recently, targeted disruption of the genes encoding the thrombin receptor PAR-114 and the G
13 protein12-13 has been shown to produce an embryonic lethal phenotype characterized by mouse embryonic day (E10) embryos failing to develop an organized vascular system. Although identifying a novel role for G protein-dependent signaling in this process, many questions remain to be answered. For instance, it is not known exactly how loss of PAR-1 or G13 protein interferes with normal vascular development. The mechanism may be direct, or the effect may be indirect resulting from the induction of proangiogenic factors such as VEGF or the transactivation of the VEGF receptor.7-11 Addressing the mechanism has been hampered by the difficulty of studying mutant embryos with early lethality in the intrauterine environment of the mouse. To overcome this limitation, we have begun to explore the use of zebrafish as a model system to identify G protein 
subunit combinations that regulate the angiogenic process in the context of the organism.
As the result of combinatorial association, there is the potential to generate several hundred unique G protein trimers from the known number of , , and subunit genes.15 Targeted disruption in mice and cell-culture study of the G protein subunit genes have revealed potential roles for the q, 11, and 13 subtypes in vascular development.12,13,16,17 However, nothing is known about the essential roles of specific and subunit genes in this process despite recent evidence showing loss of either component destroys the functional activity of the G protein trimer and disrupts coupling to the upstream receptor in mice.18,19 Identifying the subunits that partner with the q, 11, and 13 subunits to regulate vascular development has been hampered by the large sizes of the and subunit gene families.15,20,21 Because the subunit genes exhibit the greatest structural diversity, and therefore are most likely to direct the functional specificity, we initially sought to identify those subtypes specifically expressed in the developing vasculature of the zebrafish embryos as a first step in ascribing their functional roles in the context of the organism. Using the human and mouse G protein sequences to probe the zebrafish sequence database, we identified the zebrafish gng2 gene, which encodes the 71-amino acid G2 protein that is highly conserved among vertebrates (Figure 1A-B). The expression pattern of zebrafish gng2 was very dynamic during embryonic development. RT-PCR analysis showed the gng2 transcript was provided maternally from the 1-cell stage (Figure 1C) and detected zygotically throughout gastrulation and embryogenesis. Whole-mount in situ hybridization using an antisense probe revealed that gng2 was expressed ubiquitously during gastrulation (data not shown). At 18 hours after fertilization (hpf), the gng2 transcript was detected throughout the central nervous system, including the telencephalon, ventral midbrain, ventral hindbrain, and spinal cord neurons (Figure 1D). Between 18 and 24 hpf, the transcript was also expressed in the axial vasculature, including the dorsal aorta from which the intersomitic vessels sprout (Figure 1D-F). At 28 hpf, the transcript was no longer detectable in the vasculature although it was still expressed in the brain and spinal cord (Figure 1G). Between 28 and 108 hpf, the transcript was restricted to the brain (Figure S3, available on the Blood website; see the Supplemental Materials link at the top of the online article).
Targeted knockdown of zebrafish gng2 inhibits angiogenesis
In order to uncover a possible role of gng2 in vascular development, we used the morpholino antisense knockdown approach in the zebrafish embryos.22 To demonstrate the efficacy of inhibition in vivo, we designed a splice junction morpholino targeted against the first coding exon-intron boundary (Figure 2A). When injected into zebrafish embryos, the splicing morpholino induced a cryptic splicing site resulting in truncation of the coding sequence of gng2, as confirmed by sequencing of the RT-PCR products of the gng2 transcript from the knockdown embryos (Figure 2B-C).
|
|
The efficacy of this knockdown approach was confirmed using a second morpholino directed against the 5' untranslated region (UTR) spanning the ATG start codon to inhibit translation (Figure S1; Movie S3). The translation blocking morpholino specifically inhibited G2 protein expression, as validated by the in vitro translation assay (Figure S1). Both morpholino strategies produced a similar blood circulation phenotype in vivo, which was not observed in embryos injected with a 5-base mismatch control morpholino (Movie S4; mismatch control morpholino). Therefore, using 2 independent morpholinos and a mismatch control, we demonstrated that the gng2 gene was targeted in a sequencespecific manner and that targeted knockdown of gng2 disrupted the sprouting of intersomitic vessels from the axial vasculature of the zebrafish embryos. These intersomitic vessels are particularly interesting because they develop by angiogenic sprouting from the dorsal aorta and cardinal vein, a process that closely resembles tumor angiogenesis.23
|
Although they are not functional until 2.5 dpf, the intersomitic vessels begin forming around 1 dpf, coinciding with the expression of the gng2 transcript in the developing vasculature (Figure 1D-F). To visualize the developing vasculature, we used the endothelial specific marker flk1, which encodes the VEGFR-2 receptor (Flk-1/KDR).24 As shown by in situ hybridization of 1-dpf control embryos, the flk1 transcript was abundantly expressed in the cranial vessels, axial vasculature (ie, dorsal aorta and cardinal vein), and more importantly, in the intersomitic vessels sprouting from the dorsal aorta (Figure 3A,D). By contrast, in situ hybridization analysis of gng2 knockdown embryos at the same stage revealed expression of the flk1 transcript in the dorsal aorta and cardinal vein, indicating that endothelial-cell differentiation giving rise to the axial vasculature was not defective. However, gng2 knockdown embryos showed greatly reduced expression of the flk1 transcript in the region where the intersomitic vessels normally sprout from the axial vasculature (Figure 3B-C, E-F; higher magnification in Figure 3E-F). Quantitative analysis showed that 87% (392 embryos) of the gng2 knockdown embryos exhibited partial (Figure 3C,F) to complete loss of intersomitic vessels (Figure 3B,E), compared with all of the control embryos showing normal establishment of intersomitic vessels sprouting from the dorsal aorta (Figure 3A,D). Statistical analysis showed that embryos injected with gng2-MO significantly inhibited the angiogenic sprouting of intersomatic vessels to only 12% (50 embryos out of 392 embryos total) (P < .001 in a Student t test; Figure 3G). This phenotype persisted even after 30 hpf (data not shown), suggesting an actual defect rather than a delay in establishing the intersomitic vessels in the gng2 knockdown embryos.
To further confirm that the angiogenic defect is specific to the gng2 knockdown, we performed an RNA rescue experiment. Using a zebrafish gng2 mRNA without intron sequences, we demonstrated that the angiogenic defect of gng2 knockdown embryos can be significantly rescued by coinjection of this splicing-resistant form of the gng2 mRNA. Quantitative analysis showed that 58% of the gng2 knockdown embryos coinjected with morpholino and RNA displayed the presence of intersomitic vessels, compared to 13% (50 embryos) injected with morpholino alone (Figure 3G-I, P < .005 in a Student t test). The inability of RNA overexpression to completely rescue the knockdown phenotype has been observed for many other genes examined in the zebrafish model,25-29 and is most likely due to the limitation of the injected RNA to recapitulate the unique spatial and temporal expression pattern of a gene, such as gng2, in vivo. Collectively, these findings indicate that gng2 plays a critical role in angiogenesis and provides an entry point for the study of G protein signaling in this process at the in organismo level. Furthermore, they demonstrate a specific function for the G2 subtype in vivo that cannot be substituted by other family members. Future studies will be aimed at analyzing whether the failure of other G subtypes to substitute for this function is due to its characteristic expression pattern or to its unique structure in the organismal context.
gng2 genetically interacts with the vegf pathway
The gng2 knockdown phenotype shared striking similarity with that of vegf knockdown embryos,2,3 suggesting they may function in a common or converging pathway. To explore this possibility, we compared the angiogenic response to vegf in control and gng2-suppressed embryos. Interestingly, morpholino knockdown of both the vegf and gng2 transcripts revealed a synergistic effect on angiogenesis in the zebrafish embryos (Figure 3J-K). At a subeffective dosage of either morpholino alone, there was no effect on angiogenesis (Figure 3J, vegf knockdown; gng2 knockdown data not shown). However, the simultaneous inhibition of both vegf and gng2 at the same subeffective doses significantly eliminated the process of angiogenic sprouting in the zebrafish model (Figure 3K). Statistical analysis showed that simultaneous inhibition of both vegf and gng2 significantly inhibited the angiogenic sprouting of intersomitic vessels (IS) to 14% (P < .001 in a Student t test; Figure 3L).
|
G2 function is crucial for VEGF-dependent activation of PLC1 and AKT
Activation of the VEGFR-2 receptor (Flk-1/KDR) stimulates AKT kinase and PLC1 signaling molecules in vascular endothelial cells.7,30-31 To dissect the molecular pathway by which G2 interacts with VEGFR-2 during angiogenesis, we used specific antiphospho antibodies to detect the active forms of AKT kinase and PLC1 in the vasculature of developing zebrafish embryos. Upon overexpression of vegf mRNA in zebrafish embryos, we detected an activation of PLC1 and AKT kinase in the axial vasculature by whole-mount immunohistochemistry (Figure 4H,K; compare with WT in Figure 4G, J). Notably, knockdown of gng2 abolished the vegf-induced phosphorylation of both PLC1 and AKT kinase (Figure 4I,L). Statistical analysis showed that vegf121 overexpression followed by morpholino knockdown of gng2 significantly inhibited the activation of PLC1 and AKT kinase in the axial vasculature to 9% and 3%, respectively (P < .001 and .001, respectively, in Student t tests; Figure 4N-O). Thus, we have shown that G2 plays a crucial and specific role in angiogenesis by blocking downstream components of the vegf signaling pathway in vivo.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionReferences |
|---|
2 as a novel player during angiogenesis in the developing zebrafish embryos. In addition, we have shown that loss of gng2 blocks the ability of VEGF to promote angiogenic sprouting by disrupting downstream signaling to PLC1 and AKT. There is increasing evidence that GPCR/G-protein signaling can interact with the VEGF pathway. Several studies have shown that activation of GPCRs by thrombin, angiotensin, and endothelin can modulate vascular remodelling by inducing VEGF expression.11,32,33 Activation of many of these same GPCRs can also transactivate the VEGFR-2 receptor by inducing its expression and/or stimulating its tyrosine phosphorylation.7-10 Other studies have pointed to a similar involvement of G proteins in these processes,17,34 with one report describing the physical interaction of Gq/11 with Flk-1/KDR in human endothelial cells.17
However, our zebrafish study points to a different scenario (Figure 5) since targeted knockdown of gng2 disrupted the angiogenic sprouting of intersomitic vessels from the axial vasculature even though expression of flk-1 along the dorsal aorta and cardinal vein was not affected. In fact, ectopic overexpression of vegf mRNA in the gng2 knockdown embryos further induced expression of flk-1 along the dorsal aorta and cardinal vein even though the embryos still failed to develop intersomitic vessels. Thus, the autoregulatory loop for VEGF and its receptor appeared to be intact in the gng2 knockdown embryos, making it less likely that G2 interacts with VEGF signaling at the level of ligand or receptor expression. We hypothesize that G2 function is essential for VEGF-dependent pathway to regulate angiogenesis in the zebrafish model. G2 interacts with the VEGF-pathway by regulating the PLC1 and AKT, the downstream mediators of VEGF signaling pathway (Figure 5). Consistent with our hypothesis, VEGFR-2 (Flk-1/KDR) belongs to the receptor tyrosine kinase superfamily, some of whose members have been shown to use G proteins for their downstream signaling. For example, the plateletderived growth factor receptor activates mitogen-activated protein kinase (MAPK) and DNA synthesis through direct tyrosine phosphorylation of Gi,35 the insulin receptor stimulates phosphatidylinositol 3-kinase (PI3K) and glucose transport through activation of Gq,36 and the insulin like growth factor receptor activates MAPK and cell proliferation through interaction with Gi.37 Pointing to a similar requirement for a G protein in VEGFR-2 signaling, we showed that loss of G2 attenuates the VEGF-induced activation of PLC1 and AKT during angiogenesis. We speculate that loss of G2 disrupts the synthesis and assembly of the specific G heterotrimer involved in this process. This possibility is consistent with recent evidence showing the G component is required for stabilization and membrane trafficking of specific G heterotrimers.18,19,38 Because receptor activation of the G heterotrimer produces two active signaling moieties (G and G), its loss would have two consequences. First, signaling by the active G moiety would be blocked. In this regard, heterologous expression and reconstitution studies have shown that G can bind to and activate PLC1 in intestinal epithelial cells.39 Similarly, G can activate the p110 catalytic subunit of PI3K, which in turn activates AKT in the Chinese hamster ovary (CHO) cells.40,41 Although suggesting possible mechanisms, the specific combinations of G subunits involved in these processes were not determined in vivo. Based on the results of this current study, we speculate that a G dimer containing G2 may be involved in activation of 1 or both of these enzymes in vascular endothelial cells. In addition to disruption of Gmediated signaling, its loss would also block signaling by the G moiety since a specific G heterotrimer is required for the activation by receptor.42-45 The identity of the G subunit associated with G2 is not known. However, based on multiple lines of evidence, including similarity of knockout mice phenotypes, we speculate G13 or Gq/11 may be involved.12,13,16,17 This possibility will be explored in future studies.
|
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Prepublished online as Blood First Edition Paper, March 14, 2006; DOI 10.1182/blood-2005-09-3706.
Supported by National Institutes of Health (NIH) grant to J.D.R. (GM58191).
T.L. and J.D.R. participated in designing the research, analyzed the data, and wrote the paper; T.L., H.C., A.M.S., and K.E.G. participated in performing the experiments; and S.S., E.J.H., J.E.H., and C.A.H. contributed to the preliminary data leading to the final scientific discovery.
The online version of this article contains a data supplement.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Janet D. Robishaw, Weis Center for Research, Geisinger Health System, 100 N Academy Ave, Danville, PA 17822; e-mail: jrobishaw{at}geisinger.edu; and TinChung Leung, Weis Center for Research, Geisinger Health System, 100 N Academy Ave, Danville, PA 17822; e-mail: tleung1{at}geisinger.edu.
|
References |
|---|
|
TopAbstractIntroductionMaterials and methodsResultsDiscussionReferences |
|---|
13 deficiency. Science. 1997;275: 533-536.13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A. 2005;102: 8281-8286.q/11 mutant mice. EMBO J. 1998;17: 4304-4312.[CrossRef][Medline]
[Order article via Infotrieve]q/11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem. 2003;278: 20738-20745.7 alters behavior and reduces striatal Go level and cAMP production. J Biol Chem. 2003;278: 6575-6579.3 are lean and have seizures. Mol Cell Biol. 2004;24: 7758-7768. and DNA synthesis in vascular endothelial cells. EMBO J. 2001;20: 2768-2778.[CrossRef][Medline]
[Order article via Infotrieve] in vascular smooth muscle cells. J Biol Chem. 2000;275: 26765-26771.q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol. 1999;19: 6765-6774.i2 in human intestinal smooth muscle: G-dependent mitogen-activated protein kinase activation and growth. J Biol Chem. 2001;276: 7187-7194. dimers using bimolecular fluorescence complementation demonstrates roles for both G and G in subcellular targeting. J Biol Chem. 2004;279: 30279-30286. subunits and phospholipase C-gamma1 in intestinal epithelial cells. J Biol Chem. 2000;275: 9849-9853.-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110. Curr Biol. 2005;15: 566-570.[CrossRef][Medline]
[Order article via Infotrieve] in GTP-binding proteinmediated activation of Akt. Biochem J. 2005;392: 607-614.[CrossRef][Medline]
[Order article via Infotrieve]-dimers in growth and differentiation. Oncogene. 2001;20: 1653-1660.[CrossRef][Medline]
[Order article via Infotrieve]17 subunits in the betaadrenergic receptor signaling pathway. J Biol Chem. 1999;274: 17365-17371. subunit combinations differentially modulate receptor and effector coupling in vivo. Cell Signal. 2000;12: 673-682.[CrossRef][Medline]
[Order article via Infotrieve] specificity: G11 shows unique potency for A1 adenosine and 5-HT 1A receptors. Biochemistry. 2001;40: 10532-10541.[CrossRef][Medline]
[Order article via Infotrieve]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Larhammar, K. Nordstrom, and T. A. Larsson Evolution of vertebrate rod and cone phototransduction genes Phil Trans R Soc B, October 12, 2009; 364(1531): 2867 - 2880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting J. Cell Sci., April 1, 2009; 122(7): 1025 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Alsayed, H. Ngo, J. Runnels, X. Leleu, U. K. Singha, C. M. Pitsillides, J. A. Spencer, T. Kimlinger, J. M. Ghobrial, X. Jia, et al. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma Blood, April 1, 2007; 109(7): 2708 - 2717. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
2 is required for VEGF signaling during angiogenesis
